AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycinova G 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Ikon Remedies Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glycinova G 2mg/500mg Tablet ER

Diabeva Duo 2mg/500mg Extended-Release tablets are classified as antidiabetic agents. This dual-action medication, prescribed for adult-onset type 2 diabetes, effectively manages blood glucose. Diabeva Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, manifested by symptoms like sweating, dizziness, headache, and tremors. Prompt glucose replenishment (e.g., sugary foods or juice) is essential. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiac disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests assessing blood cell counts and liver function, are recommended.

Uses of Glycinova G 2mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glycinova G 2mg/500mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glycinova G 2mg/500mg Extended-Release Tablets should be administered with a meal.

Common Side effects of Glycinova G 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glycinova G 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Glycinova G 2mg/500mg Extended-Release tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. Administer this medication with a meal.

How Glycinova G 2mg/500mg Tablet ER works:

Glycinova G 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Glycinova G 2mg/500mg Extended-Release tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glycinova G tablets (2mg/500mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glycinova G tablets (2mg/500mg) are contraindicated during lactation due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glycinova G 2mg/500mg Extended-Release tablets. Dosage modification may be necessary, and medical consultation is advised. Glycinova G 2mg/500mg ER tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glycinova G 2mg/500mg Extended-Release tablets cautiously. Dosage modification of Glycinova G 2mg/500mg Extended-Release tablets may be necessary. Medical advice is recommended. For individuals with mild to moderate hepatic dysfunction, Glycinova G 2mg/500mg Extended-Release tablets are typically initiated at a reduced dose; however, their use is contraindicated in those with severe liver disease.

What if you forget to take Glycinova G 2mg/500mg Tablet ER :

Should you forget a Glycinova G 2mg/500mg Extended-Release tablet, take it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glycinova G 2mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glycinova G 2mg/500mg Tablet ER

Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Glycinova G 2mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Glycinova G 2mg/500mg Tablet ER and seek immediate medical attention.
Glycinova G 2mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glycinova G 2mg/500mg ER tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glycinova G 2mg/500mg Tablet ER use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glycinova G 2mg/500mg ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glycinova G 2mg/500mg ER tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glycinova G 2mg/500mg Tab...
78
MRP 95
17% off